NR Rose - Autoimmunity, 2008 - informahealthcare.com Increased emphasis has been placed in recent years on predictive biomarkers to
foretell the onset or future course of disease. In autoimmune diseases,
autoantibodies have proven to be valuable biomarkers because of their ... Cited by 4 - Related articles - All 6 versions
SA Dib - Arquivos Brasileiros de Endocrinologia & Metabologia, 2008 - SciELO Brasil O diabetes melito tipo 1 (DM1) caracteriza-se pela deficiência de insulina por
causa da destruição das células-beta pancreáticas. O DM1 atualmente é
classificado em dois subtipos: um auto-imune (DM1A) e outro não auto-imune ... Cited by 2 - Related articles - Cached - All 3 versions
PJ Bingley - Journal of Clinical Endocrinology & Metabolism, 2009 - Endocrine Soc Evidence Synthesis: Sensitive and specific glutamate decarboxylase and islet
antigen-2 antibody assays are widely available, although to insulin autoantibody
assays remain variable. Islet auto- antibodies appear early in life, and ...
JK Kirk, CDE PharmD, S Namak - Diabetes, 2009 - jfponline.com The USPSTF now calls for screening patients with mild hypertension. A late-onset
variant is now in the classification mix. Use these tools and tips to better
evaluate patients. ... Routinely screen adult patients with a sustained ... Related articles - Cached
SA Dib - Arq Bras Endocrinol Metab, 2008 - SciELO Brasil O diabetes melito tipo 1 (DM1) caracteriza-se pela deficiência de insulina por
causa da destruição das células-beta pancreáticas. O DM1 atualmente é
classificado em dois subtipos: um auto-imune (DM1A) e outro não auto-imune ... Related articles - Cached - All 2 versions